The actual controller of Fengyuan Pharmaceutical (000153.SZ) is set to be changed to the State-owned Assets Supervision and Administration Commission of Bengbu City.

Zhitong Finance APP reported that Fengyuan Pharmaceutical (000153.SZ) announced that it has received a notification from its controlling shareholder, Fengyuan Group. It has come to the company's attention that the controlling shareholder and related parties signed a "Share Transfer Agreement" with Bengbu Investment Group on August 14, 2026, in Bengbu City. Bengbu Investment Group intends to acquire 100 million shares of the company held by the concerted actors of Fengyuan Group through a negotiated transfer. These shares are unrestricted tradable shares, and the number of transferred shares accounts for 21.53% of the total share capital of the company as of the date of signing the agreement. Bengbu Investment Group will gain 100 million shares of the listed company through direct shareholdings, becoming the new controlling shareholder of the company.